...
首页> 外文期刊>Japanese Journal of Pharmacology >No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs.
【24h】

No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs.

机译:在犬中通过4-戊烯酸给药不引起腺苷A1受体参与急性肾毒性。

获取原文
获取原文并翻译 | 示例

摘要

Intrarenal infusion of 4-pentenoic acid is known to lower renal cortical ATP content and cause a reduction in glomerular filtration rate (GFR). The alteration in nucleotide metabolism might augment the production of adenosine, thereby eliciting the fall in GFR. This study was conducted to examine whether 4-pentenoic acid stimulates renal production of adenosine, and if so, to examine the role of adenosine A1 receptor in the reduction of GFR by 4-pentenoic acid. With infusion of 4-pentenoic acid (1 micromol x kg(-1) x min(-1)) into the renal artery of anesthetized dogs, GFR gradually decreased and reached minimum at 60 min with values ranging from 33.9+/-2.2 to 20.2+/-2.8 ml/min. Neither renal blood flow nor mean arterial pressure was affected, but tubular reabsorption of water and sodium was significantly attenuated. Renal venous plasma concentration and urinary excretion of adenosine rose markedly (20-fold) without any change in arterial concentration, suggesting that renal adenosine production was augmented by 4-pentenoic acid. However, KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a selective antagonist of the adenosine A1 receptor, did not affect the action of 4-pentenoic acid on GFR or renal handling of water and sodium. It is concluded that 4-pentenoic acid markedly increases renal adenosine production, but adenosine A1 receptor is not involved in the 4-pentenoic acid-induced nephrotoxicity.
机译:肾内输注4-戊烯酸会降低肾皮质ATP含量,并导致肾小球滤过率(GFR)降低。核苷酸代谢的改变可能会增加腺苷的产生,从而引起GFR的下降。进行该研究以检查4-戊烯酸是否刺激肾上腺苷的产生,如果是,则检查腺苷A1受体在4-戊烯酸减少GFR中的作用。在麻醉的狗的肾动脉中注入4-戊烯酸(1 micromol x kg(-1)x min(-1))后,GFR逐渐降低并在60分钟时达到最小值,其范围为33.9 +/- 2.2至20.2 +/- 2.8毫升/分钟肾血流量和平均动脉压均未受影响,但肾小管对水和钠的重吸收明显减弱。肾静脉血浆浓度和腺苷尿排泄显着上升(20倍),而动脉浓度没有任何变化,这表明4-戊烯酸可增加肾腺苷的产生。然而,腺苷A1受体的选择性拮抗剂KW-3902(8-(正丁基金刚烷-3-基)-1,3-二丙基黄嘌呤)不会影响4-戊烯酸对GFR的作用或对水和肾脏的处理。钠。结论是4-戊烯酸显着增加了肾腺苷的产生,但是腺苷A1受体不参与4-戊烯酸诱导的肾毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号